Literature DB >> 7459207

Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.

M Hacker, D Roberts, C W Jackson.   

Abstract

The haematological responses of BDF1 mice were monitored after i.v. or i.p. inoculation of L1210 leukaemic cells. Although a marked decrease in haematocrit was observed in mice given L1210 by either route, the anaemia was most pronounced after the i.p. route. The leucocyte count was more markedly increased after i.v. inoculation than after i.p. inoculation. The number of platelets decreased following either route, but was more depressed by i.v. inoculation. When mice were treated with VM-26 on Day 4 and i.p. inoculation of 10(6) L1210 cells, the haematological responses were altered. VM-26 prevented the accumulation of haemorrhagic ascites fluid and the precipitous decline in haemotacrit. However, the number of leucocytes increased dramatically, most significantly during the 48 h before death. VM-26 caused a temporary restoration of platelet count to near baseline levels. By the time of death, however, a second decrease in platelets had occurred. The results suggest that the haematological response of mice to L1210 leukaemic cells varies according to the route of inoculation, and that these tumour-induced haematological responses of the host can be modified by treatment with VM-26.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7459207      PMCID: PMC2010556          DOI: 10.1038/bjc.1980.304

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Morphology and enumeration of human blood platelets.

Authors:  G BRECHER; E P CRONKITE
Journal:  J Appl Physiol       Date:  1950-12       Impact factor: 3.531

2.  Studies of the anaemia in an acute rat leukaemia.

Authors:  E B Harriss; D Hoelzer
Journal:  Br J Haematol       Date:  1974-04       Impact factor: 6.998

3.  Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites.

Authors:  H E Skipper; F M Schabel; W S Wilcox; W R Laster; M W Trader; S A Thompson
Journal:  Cancer Chemother Rep       Date:  1965-08

4.  Shortened platelet survival as a cause of thrombocytopenia in mice with L1210 leukemia.

Authors:  C W Jackson; R A Krance; C C Edwards; M A Whidden; P A Gauthier
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

5.  Suppression of mouse erythroid colony formation by L1210 leukemia cells.

Authors:  T Austin; A Ma; M C Datta; J A Ortega; N A Shore; P P Dukes
Journal:  Exp Hematol       Date:  1979-02       Impact factor: 3.084

6.  Depression of the platelet count after inoculation of mice with L1210 or L5178Y cells.

Authors:  M Hacker; D Roberts; C Jackson
Journal:  Br J Haematol       Date:  1977-03       Impact factor: 6.998

  6 in total
  1 in total

1.  Synergistic antitumor activity of vincristine and VP-16-213.

Authors:  D V Jackson; T R Long; T F Trahey; T M Morgan
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.